NCT05304845View on ClinicalTrials.gov

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

May 22, 2022

Study Completion Date

May 22, 2022

Conditions
Drug Drug Interaction
Interventions
DRUG

DWP14012

Potassium-competitive acid blocker

DRUG

Aspirin

acetylsalicylic acid

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY